Increased superoxide levels in ganglia and sympathoexcitation are involved in sarafotoxin 6c-induced hypertension

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 295, Issue 5, 2008, Pages

  Li, Melissa ^a   Dai, Xiaoling ^a   Watts, Stephanie ^a   Kreulen, David ^b   Fink, Gregory ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Endothelin type B receptor; Neuronal regulation; Oxidative stress

Indexed keywords

ENDOTHELIN B RECEPTOR; NORADRENALIN; REACTIVE OXYGEN METABOLITE; SARAFOTOXIN S6C; SUPEROXIDE; TEMPOL;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; CAPACITANCE BLOOD VESSEL; CELIAC GANGLION; CONTROLLED STUDY; GANGLION; GANGLION BLOCK; HYPERTENSION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SYMPATHETIC GANGLION; SYMPATHETIC NERVE; SYMPATHETIC TONE;

ACRIDINES; ANIMALS; DENERVATION; ETHIDIUM; FLUORESCENT DYES; GANGLIA, SYMPATHETIC; GANGLIONIC BLOCKERS; HYPERTENSION; LUMINESCENCE; MALE; MUSCLE TONUS; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDES; SYMPATHETIC NERVOUS SYSTEM; TRIMETHAPHAN; VASOCONSTRICTOR AGENTS; VIPER VENOMS;

EID: 57349200484     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00783.2007     Document Type: Article

References (66)

1. Aneman A, Eisenhofer G, Fandriks L, Friberg P. Hepatomesenteric release and removal of norepinephrine in swine. Am J Physiol Regul Integr Comp Physiol 268: R924-R930, 1995.
2. Aneman A, Eisenhofer G, Olbe L, Dalenback J, Nitescu P, Fandriks L, Friberg P. Sympathetic discharge to mesenteric organs and the liver. Evidence for substantial mesenteric organ norepinephrine spillover. J Clin Invest 97: 1640-1646, 1996.
3. B receptor activation in angiotensin II-induced hypertension: effects of salt intake. Am J Physiol Heart Circ Physiol 281: H2218-H2225, 2001.
4. Baumer AT, Kruger CA, Falkenberg J, Freyhaus HT, Rosen R, Fink K, Rosenkranz S. The NAD(P)H oxidase inhibitor apocynin improves endothelial NO/superoxide balance and lowers effectively blood pressure in spontaneously hypertensive rats: comparison to calcium channel blockade. Clin Exp Hypertens 29: 287-299, 2007.
5. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313, 2007.
6. Biaggioni I, Robertson RM. Hypertension in orthostatic hypotension and autonomic dysfunction. Cardiol Clin 20: 291-301, 2002.
7. Brandes RP, Kreuzer J. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res 65: 16-27, 2005.
8. Callera GE, Touyz RM, Teixeira SA, Muscara MN, Carvalho MH, Fortes ZB, Nigro D, Schiffrin EL, Tostes RC. ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension. Hypertension 42: 811-817, 2003.
9. Campese VM, Ye S, Zhong H, Yanamadala V, Ye Z, Chiu J. Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. Am J Physiol Heart Circ Physiol 287: H695-H703, 2004.
10. phox in aortas from angiotensin II-infused mice. Am J Physiol Heart Circ Physiol 279: H2234-H2240, 2000.
11. Cosentino F, Sill JC, Katusic ZS. Role of superoxide anions in the mediation of endothelium-dependent contractions. Hypertension 23: 229-235, 1994.
12. B receptors by sympathetic neurons in DOCA-salt hypertensive rats. Hypertension 43: 1048-1054, 2004.
13. Degoute CS. Controlled hypotension: a guide to drug choice. Drugs 67: 1053-1076, 2007.
14. Eisenhofer G, Aneman A, Hooper D, Holmes C, Goldstein DS, Friberg P. Production and metabolism of dopamine and norepinephrine in mesenteric organs and liver of swine. Am J Physiol Gastrointest Liver Physiol 268: G641-G649, 1995.
15. Evans AM, Cobban HJ, Nixon GF. ET(A) receptors are the primary mediators of myofilament calcium sensitization induced by ET-1 in rat pulmonary artery smooth muscle: a tyrosine kinase independent pathway. Br J Pharmacol 127: 153-160, 1999.
16. Fink G, Li M, Lau Y, Osborn J, Watts S. Chronic activation of endothelin B receptors: new model of experimental hypertension. Hypertension 50: 512-518, 2007.
17. Fujita M, Ando K, Nagae A, Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension 50: 360-367, 2007.
18. Greenway CV. Role of splanchnic venous system in overall cardiovascular homeostasis. Fed Proc 42: 1678-1684, 1983.
19. Greenway CV, Lautt WW. Blood volume, the venous system, preload, and cardiac output. Can J Physiol Pharmacol 64: 383-387, 1986.
20. Griendling KK. Novel NAD(P)H oxidases in the cardiovascular system. Heart 90: 491-493, 2004.
21. Ha H, Lee HB. Reactive oxygen species and matrix remodeling in diabetic kidney. J Am Soc Nephrol 14: S246-S249, 2003.
22. Hainsworth R. Vascular capacitance: its control and importance. Rev Physiol Biochem Pharmacol 105: 101-173, 1986.
23. +/glucose cotransporter activity in renal proximal tubule cells. Am J Physiol Renal Physiol 288: F988-F996, 2005.
24. Han Y, Shi Z, Zhang F, Yu Y, Zhong MK, Gao XY, Wang W, Zhu GQ. Reactive oxygen species in the paraventricular nucleus mediate the cardiac sympathetic afferent reflex in chronic heart failure rats. Eur J Heart Fail 9: 967-973, 2007.
25. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100: 2153-2157, 1997.
26. Hottenstein OD, Kreulen DL. Comparison of the frequency dependence of venous and arterial responses to sympathetic nerve stimulation in guinea-pigs. J Physiol 384: 153-167, 1987.
27. Johnson RJ, Fink GD, Watts SW, Galligan JJ. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats. J Hypertens 20: 665-676, 2002.
28. Karim F, Hainsworth R. Responses of abdominal vascular capacitance to stimulation of splachnic nerves. Am J Physiol 231: 434-440, 1976.
29. King AJ, Osborn JW, Fink GD. Splanchnic circulation is a critical neural target in angiotensin II salt hypertension in rats. Hypertension 50: 547-556, 2007.
30. Kopkan L, Majid DS. Superoxide contributes to development of salt sensitivity and hypertension induced by nitric oxide deficiency. Hypertension 46: 1026-1031, 2005.
31. B receptors increases superoxide levels in sympathetic ganglia in vivo. Am J Physiol Regul Integr Comp Physiol 290: R90-R95, 2006.
32. Lerman LO, Nath KA, Rodriguez-Porcel M, Krier JD, Schwartz RS, Napoli C, Romero JC. Increased oxidative stress in experimental renovascular hypertension. Hypertension 37: 541-546, 2001.
33. Li L, Fink GD, Watts SW, Northcott CA, Galligan JJ, Pagano PJ, Chen AF. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation 107: 1053-1058, 2003.
34. Mark AL. Structural changes in resistance and capacitance vessels in borderline hypertension. Hypertension 6: III69-III73, 1984.
35. Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 82: 1298-1305, 1998.
36. Millette E, de Champlain J, Lamontagne D. Altered coronary dilation in deoxycorticosterone acetate-salt hypertension. J Hypertens 18: 1783-1793, 2000.
37. Mortensen LH, Pawloski CM, Kanagy NL, Fink GD. Chronic hypertension produced by infusion of endothelin in rats. Hypertension 15: 729-733, 1990.
38. A) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury. Toxicology 219: 142-149, 2006.
39. Pang CC. Autonomic control of the venous system in health and disease: effects of drugs. Pharmacol Ther 90: 179-230, 2001.
40. Peaston RT, Weinkove C. Measurement of catecholamines and their metabolites. Ann Clin Biochem 41: 17-38, 2004.
41. Perez-Rivera AA, Fink GD, Galligan JJ. Vascular reactivity of mesenteric arteries and veins to endothelin-1 in a murine model of high blood pressure. Vascul Pharmacol 43: 1-10, 2005.
42. Peuler JD, Johnson GA Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 21: 625-636, 1977.
43. Pollock DM, Allcock GH, Krishnan A, Dayton BD, Pollock JS. Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats. Am J Physiol Renal Physiol 278: F279-F286, 2000.
44. Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 70: 593-599, 1992.
45. Rothe C. Mean circulatory filling pressure: its meaning and measurement. J Appl Physiol 74: 499-509, 1993.
46. Rothe CF. Venous system: physiology of the capacitance vessels. In: Handbook of Physiology. The Cardiovascular System. Peripheral Circulation. Bethesda, MD: Am Physiol Soc, 1983, sect. 2, vol. 3, chapt. 13, p. 397-452.
47. Rothe CF. Mean circulatory filling pressure: its meaning and measurement. J Appl Physiol 74: 499-509, 1993.
48. Rothe CF. Physiology of venous return. An unappreciated boost to the heart. Arch Intern Med 146: 977-982, 1986.
49. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46: 325-415, 1994.
50. Savoia C, Schiffrin EL. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci (Lond) 112: 375-384, 2007.
51. Schiffrin EL. Endothelin and endothelin antagonists in hypertension. J Hypertens 16: 1891-1895, 1998.
52. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32: 59-64, 1998.
53. Shokoji T, Nishiyama A, Fujisawa Y, Hitomi H, Kiyomoto H, Takahashi N, Kimura S, Kohno M, Abe Y. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension 41: 266-273, 2003.
54. Somers MJ, Mavromatis K, Galis ZS, Harrison DG. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 101: 1722-1728, 2000.
55. Stjarne L, Bao JX, Gonon F, Msghina M. Nerve activity-dependent variations in clearance of released noradrenaline: regulatory roles for sympathetic neuromuscular transmission in rat tail artery. Neuroscience 60: 1021-1038, 1994.
56. Sullivan JC, Pollock JS, Pollock DM. Superoxide-dependent hypertension in male and female endothelin B receptor-deficient rats. Exp Biol Med (Maywood) 231: 818-823, 2006.
57. Swei A, Lacy F, Delano FA, Parks DA, Schmid-Schonbein GW. A mechanism of oxygen free radical production in the Dahl hypertensive rat. Microcirculation 6: 179-187, 1999.
58. Szasz T, Thakali K, Fink GD, Watts SW. A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease. Exp Biol Med (Maywood) 232: 27-37, 2007.
59. Szurszewski JH. Physiology of mammalian prevertebral ganglia. Annu Rev Physiol 43: 53-68, 1981.
60. Thakali KM, Lau Y, Fink GD, Galligan JJ, Chen AF, Watts SW. Mechanisms of hypertension induced by nitric oxide (NO) deficiency: focus on venous function. J Cardiovasc Pharmacol 47: 742-750, 2006.
61. Touyz RM, Schiffrin EL. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens 19: 1245-1254, 2001.
62. Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 122: 339-352, 2004.
63. Vaziri ND, Liang K, Ding Y. Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int 56: 1492-1498, 1999.
64. Xu H, Fink GD, Galligan JJ. Nitric oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in DOCA-salt rats. Am J Physiol Heart Circ Physiol 283: H885-H892, 2002.
65. Xu H, Jackson WF, Fink GD, Galligan JJ. Activation of potassium channels by tempol in arterial smooth muscle cells from normotensive and deoxycorticosterone acetate-salt hypertensive rats. Hypertension 48: 1080-1087, 2006.
66. Zafari AM, Ushio-Fukai M, Akers M, Yin Q, Shah A, Harrison DG, Taylor WR, Griendling KK. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 32: 488-495, 1998.